FDA Communications In Flux As HHS Assesses Mission-Critical Activities

Wooden puzzle with question marks
The FDA is determining the activities it can communicate about to the public as it navigates limits imposed by the Trump Administration. (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from US FDA

More from Agency Leadership